P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP

Associate Professor & Vice Chair

Department of Clinical Pharmacy and Outcomes Sciences, SCCP

803.777.4786 : Columbia | 803.434.2925 : Palmetto Health

Brandon Bookstaver

About Brandon

Brandon Bookstaver, PharmD, is an Associate Professor and Vice Chair in the Department of Clinical Pharmacy and Outcomes Sciences at the South Carolina College of Pharmacy in Columbia, South Carolina.  He also maintains a practice site in infectious diseases at Palmetto Health Richland.  Brandon received his Doctor of Pharmacy degree from the University of South Carolina College of Pharmacy in 2004.  He completed a pharmacy practice residency (2004-2005) and an infectious diseases specialty residency (2005-2006) at Wake Forest University Baptist Medical Center.  Brandon is a Board Certified Pharmacotherapy Specialist with Added Qualifications in Infectious Diseases and an HIV Expert through the American Academy of HIV Medicine.  His research areas include antimicrobial lock therapy, Clostridium difficile infections, antimicrobial dosing in obesity, HIV adherence and pharmacy trainee scholarship. 

Brandon has received numerous teaching and research awards, including most recently the 2011 American College of Clinical Pharmacy New Educator award, University of South Carolina Clinical Teaching Award (2012) and the South Carolina Pharmacist of the Year for 2011-2012.  Brandon has served on a number of regional and national groups including the Southeastern Pharmacy Residency Conference executive committee (Chairperson 2011-2012), the South Carolina Society of Health-System Pharmacists (President, 2013) and the ACCP Infectious Diseases PRN (Chair Elect, 2013).  He has published over 35 peer-reviewed publications in a number of high impact pharmacy and medical journals and recently, the well-respected text, Roadmap to Postgraduate Training, a blueprint for students and preceptors on preparing for residency and fellowship training.  Outside of work, he enjoys Gamecock athletics, running and traveling.      

Research Interests


  • Antimicrobial lock therapy
  • Obesity related outcomes in infectious diseases
  • Hospital-acquired infections; 

                    Clostridium difficile; HIV/AIDS 

  • Trainee research


  • Board Certified Pharmacotherapy Specialist, 2005
  • Added qualifications in Infectious Diseases, 2007
  • American Academy of HIV Pharmacy Expert, 2010



Doctor of Pharmacy,University of South Carolina College of Pharmacy, 2004

Dr. Bookstaver in the Media

Is there a Pharmacist in the house?

2014 Outstanding Young Alumnus 


PGY1 Pharmacy Practice Residency
Wake Forest University Baptist Medical Center, 2005

PGY2 Infectious Diseases Specialty Residency
Wake Forest University Baptist Medical Center, 2006

Practice Site

Clinical Pharmacy Specialist
Infectious Diseases,
Palmetto Health Richland


Bookstaver ResearchGate      Bookstaver PubMed


  • Bookstaver PB, Bland CM. Gastrointestinal Infections/Clostridium difficile infections/Travel Prophylaxis. In: Ambulatory Care Self-Assessment Program, 1st ed. American College of Clinical Pharmacy, Lenexa, KS. (Released: Summer 2013)
  • Bookstaver PB, Ahmed Y, Millisor VE, Siddiqui W, Albrecht HA. Clostridium difficile: Case report and concise review of fecal microbiota transplantation. J SC Med Assoc 2013;109:62-6.
  • Kelly LS, Caulder CR, Bookstaver PB. Timely formulary management for preventing errors related to antiretroviral drugs. Am J Health-Syst Pharm 2013;70:1014-5.
  • Bookstaver PB, Bland CM, Qureshi ZP, Faulkner-Fennell C, Rudisill CN, Sheldon MA, Hartis C and SERGE-45 Investigators. Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the Southeastern United States. Pharmacotherapy 2013 May 26 (Epub ahead of print).
  • Lead Editor, For: Bookstaver PB, Caulder CR, Smith KA Quidley AM. Roadmap to Postgraduate Training in Pharmacy. 1st ed. New York, NY: McGraw-Hill. Released February 2013.
  • Bookstaver PB, Enoch CB, Sutton SS. Biostatistics training through the eyes of residency program directors. Ann Pharmacother 2013;47:759-60.
  • Bookstaver PB, Miller AD. CNS Infections. In: Chisolm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice. 3rd ed. New York, NY: McGraw-Hill; (Released: January 2013).
  • Bookstaver PB, Miller AD, Felder TE, Tice DL, Norris LB, Sutton SS. Assessing Pharmacy Residents' Perception and Understanding of Biostatistics. Ann Pharmacother 2012;46:991-9.
  • Shamroe CL, Bookstaver PB, Rokas KEE, Weissman SB. Role of raltegravir and new integrase inhibitors in HIV-1 management. South Med J 2012;105:370-8.
  • Bookstaver PB. Human-Immunodeficiency Virus and Opportunistic Infections. In: Pharmacotherapy Self-Assessment Program, 8th ed. American College of Clinical Pharmacy Lenexa, KS. (Released: January 2012).
  • Bosso JA, Nappi J, Rudisill CN, Wellein M, Bookstaver PB, Swindler J, Mauldin PD. The relationship between vancomycin trough concentrations and nephrotoxicity: A prospective, multicenter trial. Antimicrob Agents Chemother 2011;55:5475-9. (E-pub 26 September 2011) Varner TR, Bookstaver PB, Rudisill CN, Albrecht HA. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila infection. Ann Pharmacother 2011;45:967-76. (E-pub 20 Jul 2011).
  • Miller AD, Bookstaver PB, DiPiro JT. Teaching clinicians about drugs – 50 years later, a role of the pharmacist. N Engl J Med 2011;364:2560, author reply 2561.
  • Musgrave CR, Bookstaver PB, Sutton SS, Miller AD. Use of alternative pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection. Int J Infect Dis 2011;15:e438-48. (E-pub 18 May 2011).
  • Miller AD, Ball A, Bookstaver PB, Dornblaser E, Bennett CL. The epileptogenic potential of carbapenem agents: mechanism of action, incidence, and clinical considerations. Pharmacotherapy 2011;31:408-23.